Madagascar
Research Article
Chronic Haemodialysis in Befelatanana, Madagascar and its Bacterial Complication
Author(s): Eliane Mikkelsen Ranivoharisoa, Benja Ramilitiana, Olivah Henintsoa Rakotonirainy, Harinjara Razanakoto, Fahafahantsoa Rapelanoro Rabenja and Willy Franck Harilalaina RandriamarotiaEliane Mikkelsen Ranivoharisoa, Benja Ramilitiana, Olivah Henintsoa Rakotonirainy, Harinjara Razanakoto, Fahafahantsoa Rapelanoro Rabenja and Willy Franck Harilalaina Randriamarotia
Patients with Chronic kidney Disease (CKD) are fragile. Hemodialysis, the most useful Renal Replacement Therapy in the world is the only treatment available in Madagascar. It is an invasive act exposing several complications. This study aims to assess the prevalence of the bacterial complication in hemodialysis. We conducted a retrospective, exhaustive, descriptive single centre study. Record based study was carried in Befelatanana Hemodialysis Centre, in Antananarivo, the Capital. All chronic hemodialyzed patients who presented an infection were included. Over 136 infections have been suspected but only 33.8% benefited a bacterial identification. In 42.65% of cases, infection begun in 20 days following the first hemodialysis session. Access vascular using catheter is the principal source of infection in 49.06%, followed by pulmonary infection. Staphylococcus aureus (34.3%) was the ba.. Read More»
DOI:
10.4172/2161-0959.1000281
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report